Besarab, A <br/><br/>
Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?  [electronic resource] 

 -  ASAIO journal (American Society for Artificial Internal Organs : 1992)   
 - 11-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1058-2916 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia--drug therapy<br/>Centers for Medicare and Medicaid Services, U.S.<br/>Drug Administration Schedule<br/>Drug Costs<br/>Erythropoietin--administration & dosage<br/>Hemodialysis Units, Hospital--economics<br/>Humans<br/>Kidney Failure, Chronic--complications<br/>Medicare--economics<br/>Recombinant Proteins--administration & dosage<br/>Reimbursement Mechanisms<br/>Renal Dialysis--economics<br/>United States<br/>United States Food and Drug Administration